Cartesian Therapeutics Inc. held its Annual Meeting of Stockholders on June 13, 2025. During the meeting, stockholders voted on several proposals. The election of three Class III Directors, Timothy C. Barabe, Carsten Brunn, and Nishan de Silva, was approved. Additionally, the appointment of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2025, was ratified.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cartesian Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001453687-25-000093), on June 16, 2025, and is solely responsible for the information contained therein.